NMI bladder cancer: which adjuvant intravesical therapy is best?

Access to the full content of this site is available only to registered healthcare professionals. Register to read more
Takeaway
  • Compared with transurethral resection of the bladder tumor (TURBT) alone, intravesical bacillus Calmette-Guérin (BCG), mitomycin C (MMC), doxorubicin, and epirubicin were associated with reduced recurrence risk in non-muscle-invasive bladder cancer (NMIBC).  

Why this matters

  • Evid...